Post-approval studies (Phase 4)Study completedNCT01453036What this trial is testingClarithromycin Resistant Tailored TherapyWho this might be right forPeptic UlcerHelicobacter Pylori Infection Jin Il Kim 924
Testing effectiveness (Phase 2)Study completedNCT01962363What this trial is testingEPI-743 in Friedreich's Ataxia Point MutationsWho this might be right forFriedreich's Ataxia University of South Florida 4
Not applicableStudy completedNCT03884348What this trial is testingTailored H. Pylori Eradication Based on Clarithromycin ResistanceWho this might be right forHelicobacter Pylori InfectionAntibiotic Resistant Strain Kangdong Sacred Heart Hospital 431
Not applicableUnknownNCT04163159What this trial is testingGenetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa RicaWho this might be right forMetastatic Breast CancerMutation, Point Universidad de Costa Rica 25
Early research (Phase 1)Ended earlyNCT01804530What this trial is testingPhase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid TumorsWho this might be right forSolid TumorTumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsTenosynovial Giant Cell Tumor Plexxikon 59
Testing effectiveness (Phase 2)Ended earlyNCT04534283What this trial is testingA Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.Who this might be right forCancerCancer MetastaticBRAF V600E+4 more Anita Turk 16
Early research (Phase 1)Looking for participantsNCT07361562What this trial is testingA Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene Amplification+3 more Cogent Biosciences, Inc. 100
Testing effectiveness (Phase 2)UnknownNCT01955421What this trial is testingErlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant NsclcWho this might be right forAdvanced Stage Non Small Cell Lung Cancer Sun Yat-sen University 224
Early research (Phase 1)Looking for participantsNCT07383506What this trial is testingMutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid TumorsWho this might be right forPIK3CA MutationsAdvanced Solid Tumors, AdultEndometrial Cancer+2 more Cogent Biosciences, Inc. 90
Testing effectiveness (Phase 2)UnknownNCT00457314What this trial is testingThe Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle DiseaseWho this might be right forMitochondrial Myopathy National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06782932What this trial is testingComparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Testing effectiveness (Phase 2)Ended earlyNCT02634827What this trial is testingMidostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 MutationWho this might be right forAcute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsFLT3 Tyrosine Kinase Domain Point Mutation+2 more Mayo Clinic 1
Testing effectiveness (Phase 2)Study completedNCT00831974What this trial is testingEfficacy of AB1010 in Patients With Systemic Indolent MastocytosisWho this might be right forMastocytosis AB Science 23
Testing effectiveness (Phase 2)Study completedNCT01266369What this trial is testingMasitinib in Patients With Mastocytosis With Handicap and Bearing the D816V MutationWho this might be right forMastocytosis AB Science 21
Not applicableStudy completedNCT00959504What this trial is testingDetection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNAWho this might be right forDetection and Genotyping of Factor V and Factor II Point Mutations Illumina, Inc. 275
Post-approval studies (Phase 4)Study completedNCT03130452What this trial is testingHelicobacter Pylori Eradication StudyWho this might be right forHelicobacter Pylori Infection Inje University 423
Not applicableUnknownNCT03566745What this trial is testingElucidating the Molecular and Biochemical Basis of the Human AhR-mutation DiseaseWho this might be right forMutation, Point Hillel Yaffe Medical Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06142617What this trial is testingA Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.Who this might be right forNon Small Cell Lung CancerImmune Checkpoint InhibitorEGFR Exon 21 Mutation Peking Union Medical College Hospital 37
Not applicableUnknownNCT01695512What this trial is testingDiagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised PatientsWho this might be right forInvasive AspergillosisAcute LeukemiaBiomarkers+1 more Heidelberg University 200